Dar Al Dawa Development and Investment Company PSC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dar Al Dawa Development and Investment Company PSC with three other
pharmaceutical manufacturers in Middle East:
Alexandria Pharmaceuticals and Chemical Industries Co
sales of 650.00 million Egyptian Pounds [US$39.93 million]
Kahira Pharmaceuticals and Chemical Industries Co SAE
(862.95 million Egyptian Pounds [US$53.01 million]
The Jordanian Pharmaceutical Man. Co PLC
(28.18 million Jordanian Dinars [US$39.75 million]
of which 100%
Dar Al Dawa Development and Investment Company PSC reported sales of 55.10 million Jordanian Dinars (US$77.71 million)
December of 2018.
increase of 5.3%
versus 2017, when the company's sales were 52.32 million Jordanian Dinars.
Despite this increase, sales are still
below the level achieved in 2016, when Dar Al Dawa Development and Investment Company PSC
reported sales of 60.88 million Jordanian Dinars.
Sales of Infant Food and Milk saw an increase
that was more than double the company's growth rate: sales were up
32.2% in 2018, from
10.33 million Jordanian Dinars to 13.65 million Jordanian Dinars.
Not all segments of Dar Al Dawa Development and Investment Company PSC experienced an increase in sales in 2018:
sales of Pharmaceuticals fell 1.3% to 41.45 million Jordanian Dinars.